Study of the Month, September 2025: Tissue-Level Zirconia Implants in High-Risk Patients

Introduction

This case study demonstrates how tissue-level zirconia implants can be successfully used in high-risk patients, in this case, a smoking patient. This report emphasizes the importance of material selection, preventive diagnostics, and patient-centered follow-up for long-term treatment success.  

Objectives 

This study aimed to evaluate the efficacy and safety of tissue-level zirconia implants in patients with an increased risk of peri-implantitis.  

• Minimally invasive surgery without vertical releasing incisions 
• Supporting healing through supplementation and PRF 
• Preserving hard and soft tissue using specialized implant designs (oval in the anterior region, “balcony” in the molar region) 
• Reducing inflammatory parameters and promoting systemic health 

Conclusion

The patient received eight zirconia implants and achieved a 100% survival rate after eight months. No infections or complications occurred, and the gingival health improved significantly. Inflammatory markers decreased, and the patient reported enhanced quality of life. Thus, tissue-level zirconia implants represent a promising solution for high-risk patients, particularly those with increased susceptibility to peri-implant diseases. 

Reference

The full study was published under the title “Use of Tissue-Level Zirconia Implants in High-Risk Patients” in Implantology Journal 7+8/25.